Recombinant HBV (Lenvervimab Biosimilar) antibody

Catalog No. ABIN7597777

The Humanized Chimeric anti-HBV (Lenvervimab Biosimilar) antibody has been validated for not_set. It is suitable to detect HBV (Lenvervimab Biosimilar) in samples from Hepatitis B Virus (HBV).

Quick Overview for Recombinant HBV (Lenvervimab Biosimilar) antibody (ABIN7597777)

Target: HBV (Lenvervimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Hepatitis B Virus (HBV)

Host: Humanized

Clonality: Chimeric

Conjugate: This HBV (Lenvervimab Biosimilar) antibody is un-conjugated

Grade: Research Grade

Product Details anti-HBV (Lenvervimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Lenvervimab Biosimilar Antibody

Specificity: Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1, kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for HBV (Lenvervimab Biosimilar)

Target: HBV (Lenvervimab Biosimilar)

Alternative Name: Lenvervimab Biosimilar

Target Type: Biosimilar

Background: Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S

UniProt: P03142-3

CAS-No: 2055006-79-4